PTPA and leukemia: PP2A has been shown to be genetically altered or functionally inactivated in many solid cancers and leukemia, and inhibition of PP2A activity or loss of some of its functional subunits is critical to promote cell transformation, tumor progression, and angiogenesis, which indicates that PP2A has tumor suppressive roles [7-9].